Clinical Trial Update: D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring D-cycloserine as a novel treatment for Gulf War Illness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gulf War Illness

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Boston University Charles River Campus | Conditions: Gulf War Illness | Phase 2 | Status: UNKNOWN